Sprout Capital VII, L.P. (Healthcare Technology Portfolio) $ amounts in millions, as of March 31, 2014 Please refer to Endnotes 1,],K,L,M and N in this Appendix. Multiple Gross Vintage Total Realized Unrealize Total (Realized Multiple Company Sector Year Cost Value d Value Value Portion) (Total) Gross IRR Allos Therapeutics, Inc. Therapeutics 1998 $ 35 §$ 98 $ - $ 9.8 2.83 2.83 47.6% AviaHealth, Inc. (fka GoToMyDoc) Convergence 2000 $ 20 $ 0.0 $ - $ 0.0 0.02 0.02 -92.8% Cephalon, Inc. Therapeutics 1999 $ 51 $ 25.6 $ - $ 25.6 5.01 5.01 293.2% Charles River Laboratories Diagnostics & Infrastructure 1999 $ 43 $ 22.7 $ - $ 22.7 5.23 5,23 121.6% Deltagen, Inc. Therapeutics 1998 $ 199 $ 41 $ - $ 4.1 0.20 0.20 -30.3% eHealth, Inc. Convergence 1999 $ 11.3 $ 20.3 $ - $ 20.3 1.80 1.80 7.7% Gantech International, Inc. Therapeutics 1999 $ 28 §$ = $ - $ = 2 s NM Keravision Inc. Healthcare Devices 1998 $ 10.2 §$ = $ - $ - = - NM Microban International, Ltd. Diagnostics & Infrastructure 1999 $ 14.8 $ 39.7 §$ - $ 39.7 2.68 2.68 14.5% Nuvelo, Inc. (fka Variagenics, Inc.) Therapeutics 1999 $ 11.8 $ 24.8 $ - $ 24.8 2.10 2.10 13.9% NxStage Medical, Inc. Healthcare Devices 1999 $ 17.8 $ 50.3 $$ - $ 50.3 2.83 2.83 14.2% Phase Forward Incorporated Convergence 1998 $ 90 §$ 38.6 $$ - $ 38.6 431 4.31 22.4% SGX, Inc. Therapeutics 2000 $ 150 §$ 16 $ - $ 1.6 0.11 0.11 -35.3% Skila, Inc. Convergence 1998 $ 90 §$ 0.0 $ - $ 0.0 0.00 0.00 NM Spotfire, Inc. Convergence 1999 $ 99 §¢ 24.8 $ - $ 24.8 2.50 2.50 12.7% VascA, Inc. Healthcare Devices 1999 $ 73 0.1 $ - $ 0.1 0.02 0.02 NM VNUS Medical Technologies, Inc. Healthcare Devices 1999 $ 38 $ 11.1 $ - $ 11.1 2.90 2.90 12.7% Total Sprout Capital VII, L.P. (HCT) Investments $ 157.5 $ 273.7 §$ - $ 273.7 1.74 1.74 10.1% 92 CONTROL NUMBER 257 - CONFIDENTIAL HOUSE _OVERSIGHT_024103